Abstract
This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Cite
CITATION STYLE
Guerra, B., Martín-Rodríguez, P., Díaz-Chico, J. C., McNaughton-Smith, G., Jiménez-Alonso, S., Hueso-Falcón, I., … Fernández-Pérez, L. (2018, August 14). Correction: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia [Oncotarget, 8 (2017) (29679-29698)] Doi: 10.18632/oncotarget.11425. Oncotarget. Impact Journals LLC. https://doi.org/10.18632/oncotarget.26008
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
